In vitro antiviral efficacy of the ganciclovir complexed with β-cyclodextrin on human cytomegalovirus clinical strains

Antiviral Research

Volumn 54, Issue 2, 2002, Pages 121-127

  Nicolazzi, Céline ^a   Venard, Véronique ^a   Le Faou, Alain ^a   Finance, Chantal ^b  

^a NANCY UNIVERSITÉ   (France)

^b Facult   (France)

Author keywords

Cyclodextrins; Drug carrier; Ganciclovir resistance; Human cytomegalovirus

Indexed keywords

BETA CYCLODEXTRIN; DRUG CARRIER; GANCICLOVIR;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG ISOLATION; DRUG RESEARCH; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IN VITRO STUDY; MOLECULE; PRIORITY JOURNAL; VIRUS STRAIN;

ANTIGENS, VIRAL; ANTIVIRAL AGENTS; BETA-CYCLODEXTRINS; CYCLODEXTRINS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; DRUG CARRIERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; GANCICLOVIR; HUMANS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0036231791     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(01)00218-2     Document Type: Article

References (39)

1. Beta-cyclodextrin derivatives as carriers to enhance the antiviral activity of an antisense oligonucleotide directed toward a coronavirus intergenic consensus sequence
2. Rapid detection of cytomegalovirus strains resistant to ganciclovir through mutations within the gene UL97
3. Complexation study and anticellular activity enhancement by doxorubicin-cyclodextrin complexes on a multi-drug-resistant adenocarcinoma cell line
4. Antiviral activity of ganciclovir elaidic acid ester against herpesviruses
5. Increased efficacy of ganciclovir and foscarnet inhibition of cytomegalovirus replication in vitro by encapsulation in liposomes
6. Emergence of a ganciclovir-resistant human cytomegalovirus strain with a new UL97 mutation in an AIDS patient
7. Therapeutic applications of colloidal drug carriers
8. Inhibition of cytomegalovirus late antigen expression and cytomegalovirus replication in human fibroblasts and differentiated monocytic cells by liposome-encapsulated foscarnet
9. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation
10. Analysis of the UL-97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance
11. Interstrain variation in the human cytomegalovirus DNA polymerase sequence and its effect on genotypic diagnosis of antiviral drug resistance
12. Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments
13. Summary of the II International Symposium on Cytomegalovirus
14. Pharmaceutical applications of cyclodextrins
15. Resistance of human cytomegalovirus to antiviral drugs
16. Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients
17. Genetic analysis of a clinical isolate of human cytomegalovirus exhibiting resistance against both ganciclovir and cidofovir
18. Phase-solubility techniques
19. Cyclodextrins in peptide and protein delivery
20. Phase I study of combination therapy with intravenous cidofovir and oral ganciclovir for cytomegalovirus retinitis in patients with AIDS
21. Comparison of human cytomegalovirus DNA polymerase activity for ganciclovir-resistant and -sensitive clinical strains
22. Water-soluble β-cyclodextrins in paediatric oral solutions of spironolactone: Preclinical evaluation of spironolactone bioavailability from solutions of β-cyclodextrin derivatives in rats
23. Pharmacokinetic profile of piroxicam β-cyclodextrin, in rat plasma and lymph
24. Intravenous cidofovir for peripheral cytomegalovirus retinis in patients with AIDS
25. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization
26. Cyclodextrins in ophthalmic drug delivery
27. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis
28. Cyclodextrins in transdermal and rectal delivery
29. Résistance du cytomégalovirus humain aux antiviraux
30. Ganciclovir-loaded albumin nanoparticles: Characterization and in vitro release properties
31. Inclusion complexes of tretinoin with cyclodextrins
32. Interactions of ketoprofen and ibuprofen with β-cyclodextrins in solution and in the solid state
33. Effect of the complexation with cyclodextrins on the in vitro antiviral activity of ganciclovir against human cytomegalovirus
34. Extraction au phénol des acides nucléiques
35. Ganciclovir - A pharmacoeconomic review of its use as intravenous or oral maintenance therapy in the management of cytomegalovirus retinitis in patients with AIDS
36. Fomivirsen
37. High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes
38. Application of cyclodextrins
39. Ganciclovir-loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus